£76.47

Academic Press Translational Advances in Gynecologic Cancers

Price data last checked 45 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 46 days • 46 data points (No recent data available)

Historical
Generating forecast...
£76.47 £72.65 £74.18 £75.71 £77.23 £78.76 £80.29 25 January 2026 05 February 2026 16 February 2026 27 February 2026 11 March 2026

Price Distribution

Price distribution over 46 days • 1 price levels

Days at Price
46 days 0 12 23 35 46 £76 Days at Price

Price Analysis

Most common price: £76 (46 days, 100.0%)

Price range: £76 - £76

Price levels: 1 different prices over 46 days

Description

Product Description Translational Advances in Gynecologic Cancers straddles the bench and bed divide by highlighting important and interesting research that is translatable to the clinic. The contents of this book cover the entire spectrum, from promising laboratory based research, to clinical trial efforts. Further, new therapeutic indications based upon randomized phase III trials are also included. Clinicians will learn about lab-based science that is about to enter the clinic, along with the rationale behind translational endpoints in trials. Researchers will be able to identify and understand the clinical needs of patients with these types of tumors to improve their research focus. Review A quick but comprehensive update on clinically relevant advances in gynecologic cancer research About the Author Dr. Michael Birrer is a Professor of Medicine at Harvard Medical School, the Director of Medical Gynecologic Oncology, Gynecologic Oncology Research Program, and the Gellete Center for Gynecologic Oncology at Massachusetts General Hospital (MGH) in Boston, Massachusetts. He is also a practicing physician at MGH. The Birrer laboratory has had a long-term interest in characterizing the molecular origins of gynecologic cancers. This interest includes the identification and characterization of mutations in oncogenes and tumor suppressor genes within cancers of the ovary, endometrial and cervix. In addition, they have extensively characterized the differential gene expression in these tumors. The role of these genes in the development of these cancers has been tested using in vitro and in vivo model systems. The laboratory is focused on using the genomic events characterized in these cancers to produce translational science endeavors, which will result in clinically important discoveries. These genomic abnormalities form the basis for early detection assays, prevention strategies, and novel therapeutic approaches. Dr. Birrer’s laboratory focuses on bench-to-bedside-and-back-again approaches to produce clinically relevant strategies to better manage women with these cancers.MD, Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA, USA

Product Specifications

Format
Paperback
Domain
Amazon UK
Release Date
13 February 2017
Listed Since
30 September 2016

Barcode

No barcode data available

Similar Products You Might Like

Gynecologic Cancer Care: Innovative Progress (Volume 46-1) (The Clinics: Internal Medicine, Volume 46-1)
94% match

Gynecologic Cancer Care: Innovative Progress (Volume 46-1) (The Clinics: Internal Medicine, Volume 46-1)

Elsevier

£68.41 06 Mar 2026
Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)
93% match

Frontiers in Ovarian Cancer Science (Comprehensive Gynecology and Obstetrics)

Springer

£135.35 08 Mar 2026
Ovarian Cancer Biomarkers: Mapping to Improve Outcomes
93% match

Ovarian Cancer Biomarkers: Mapping to Improve Outcomes

Springer

£103.30 02 Apr 2026
Gynecologic Radiation Oncology: A Practical Guide
93% match

Gynecologic Radiation Oncology: A Practical Guide

Lippincott Williams and Wilkins

£88.34 26 Jan 2026
Tumor Microenvironment: State of the Science: 1263 (Advances in Experimental Medicine and Biology, 1263)
93% match

Tumor Microenvironment: State of the Science: 1263 (Advances in Experimental Medicine and Biology, 1263)

Springer

£109.96 02 Mar 2026
Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)
93% match

Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)

Academic Press

£117.19 06 Mar 2026
Illuminating Colorectal Cancer Genomics by Next-Generation Sequencing: A Big Chapter in the Tale
93% match

Illuminating Colorectal Cancer Genomics by Next-Generation Sequencing: A Big Chapter in the Tale

Springer

£116.58 10 Feb 2026
Stem Cells and Cancer (Cancer Drug Discovery and Development)
93% match

Stem Cells and Cancer (Cancer Drug Discovery and Development)

Humana

£148.78 19 Apr 2026
Molecular Genetics of Endometrial Carcinoma: 943 (Advances in Experimental Medicine and Biology, 943)
93% match

Molecular Genetics of Endometrial Carcinoma: 943 (Advances in Experimental Medicine and Biology, 943)

Springer

£113.11 27 Jan 2026
Principles and Practice of Gynecologic Oncology
93% match

Principles and Practice of Gynecologic Oncology

Lippincott Williams & Wilkins

£168.64 26 Jan 2026
Principles of Gynecologic Oncology Surgery
93% match

Principles of Gynecologic Oncology Surgery

Elsevier

£167.81 23 Jan 2026
Uterine Cancer: Diagnosis and Treatment
93% match

Uterine Cancer: Diagnosis and Treatment

Springer

£93.19 09 Mar 2026
Springer Uterine Cancer: Screening, Diagnosis, and Treatment
93% match

Springer Uterine Cancer: Screening, Diagnosis, and Treatment

Springer

£104.04 18 Apr 2026
Advances in Cancer Research: Volume 142
93% match

Advances in Cancer Research: Volume 142

Academic Press

£103.99 17 Feb 2026
Advances in Cancer Research: Volume 130
93% match

Advances in Cancer Research: Volume 130

Academic Press

£110.59 08 Mar 2026
Endometrial Cancer: Clinical and Translational Update Book
93% match

Endometrial Cancer: Clinical and Translational Update Book

£135.73 18 Apr 2026
Tumor Microenvironment: Novel Concepts: 1329 (Advances in Experimental Medicine and Biology, 1329)
93% match

Tumor Microenvironment: Novel Concepts: 1329 (Advances in Experimental Medicine and Biology, 1329)

£157.00 13 Jan 2026
Precision Medicine in Gynecology and Obstetrics (Comprehensive Gynecology and Obstetrics)
93% match

Precision Medicine in Gynecology and Obstetrics (Comprehensive Gynecology and Obstetrics)

Springer

£111.81 09 Mar 2026
Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 1: Biology and Pathophysiology
93% match

Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 1: Biology and Pathophysiology

Academic Press

£108.99 01 Apr 2026
Advances in Cancer Research (Volume 144)
93% match

Advances in Cancer Research (Volume 144)

Academic Press

£111.35 24 Feb 2026
Tumor Microenvironment: Molecular Players – Part B: 1277 (Advances in Experimental Medicine and Biology, 1277)
92% match

Tumor Microenvironment: Molecular Players – Part B: 1277 (Advances in Experimental Medicine and Biology, 1277)

Springer

£109.85 12 Mar 2026
Tumor Microenvironment: Non-Hematopoietic Cells: 1234 (Advances in Experimental Medicine and Biology, 1234)
92% match

Tumor Microenvironment: Non-Hematopoietic Cells: 1234 (Advances in Experimental Medicine and Biology, 1234)

Springer

£74.22 27 Mar 2026
Tumor Microenvironment: Extracellular Matrix Components – Part B: 1272 (Advances in Experimental Medicine and Biology, 1272)
92% match

Tumor Microenvironment: Extracellular Matrix Components – Part B: 1272 (Advances in Experimental Medicine and Biology, 1272)

Springer

£109.43 02 Mar 2026
Mechanisms and Therapy of Liver Cancer (Volume 149) (Advances in Cancer Research, Volume 149)
92% match

Mechanisms and Therapy of Liver Cancer (Volume 149) (Advances in Cancer Research, Volume 149)

Academic Press

£104.89 27 Feb 2026